Yumanity Therapeutics (FRA:8IY) Other Long Term Assets : €0.05 Mil (As of Sep. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Other Long Term Assets?

Yumanity Therapeutics's other long-term assets for the quarter that ended in Sep. 2022 was €0.05 Mil.

Yumanity Therapeutics's quarterly other long-term assets declined from Mar. 2022 (€0.80 Mil) to Jun. 2022 (€0.05 Mil) but then increased from Jun. 2022 (€0.05 Mil) to Sep. 2022 (€0.05 Mil).

Yumanity Therapeutics's annual other long-term assets increased from Dec. 2019 (€0.13 Mil) to Dec. 2020 (€2.22 Mil) but then declined from Dec. 2020 (€2.22 Mil) to Dec. 2021 (€1.15 Mil).

Yumanity Therapeutics Other Long Term Assets Historical Data

The historical data trend for Yumanity Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Other Long Term Assets Chart

Yumanity Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Other Long Term Assets

0.13

2.22

1.15

Yumanity Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Other Long Term Assets	Get a 7-Day Free Trial							1.12	1.15	0.80	0.05	0.05

Yumanity Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Yumanity Therapeutics (FRA:8IY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Guest Street, Suite 4410, Boston, MA, USA, 02135

Website

https://www.yumanity.com

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines